Psyence Biomedical Ltd.
PBM
Get informed when a big investor buys or sells
+ FollowMarket Cap$58.39K
Close$
$7.60
157.7% upside
Current Fair Value
157.7% upsideUndervalued by 157.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $58,388.00 |
|---|---|
| Enterprise Value | $-7,138,788.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 1.68 |
| Outstanding Shares | 1,481,527 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.37 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 24, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 10.22%▲ 9.74% |
|---|---|
| Total Invested | $574,968▲ 1713.78% |
| Investors Holding | 2▼ 2.00% |
ESG Score
No data